Penny Stock Insider Trading
Tracking Executive Conviction in Stocks Under $5
Insider Activity in Low-Priced Equities
Insider trading in penny stocks often carries significant weight due to the high volatility inherent in smaller companies. When a director or CEO of a low-cap firm purchases shares, it can signal a major belief in an upcoming fundamental shift.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-23 03:34 | 2026-01-20 | RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Biological Products, (No Diagnostic Substances) | SELL | $4.47 | 40,000 | -$178,800 | 913,839 | -4.2% |
| 2026-01-23 00:16 | 2026-01-20 | MNTR | Mentor Capital, Inc. | Billingsley Chester | Director, Officer, 10% owner - Chief Executive Officer | Investors, NEC | BUY | $0.09 | 3,800 | $336 | 3,165,296 | +0.1% |
| 2026-01-22 15:00 | 2026-01-21 | RNXT | RenovoRx, Inc. | Agah Ramtin | Director, Officer - Chief Medical Officer | Pharmaceutical Preparations | BUY | $1.00 | 10,000 | $9,975 | 798,460 | +1.3% |
| 2026-01-23 05:55 | 2026-01-16 | RMCF | Rocky Mountain Chocolate Factory, Inc. | GLOBAL VALUE INVESTMENT CORP. | 10% owner | Sugar & Confectionery Products | BUY | $1.98 | 11,300 | $22,353 | 1,971,306 | +0.6% |
| 2026-01-23 02:49 | 2026-01-22 | DTIL | PRECISION BIOSCIENCES INC | Amoroso Michael | Director, Officer - President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $4.17 | 34,799 | -$145,112 | 196,154 | 0.0% |
| 2026-01-23 02:48 | 2026-01-21 | DTIL | PRECISION BIOSCIENCES INC | Scimeca Dario | Officer - General Counsel and Secretary | Biological Products, (No Diagnostic Substances) | OPT+S | $4.03 | 8,854 | -$35,682 | 44,715 | 0.0% |
| 2026-01-23 02:48 | 2026-01-21 | DTIL | PRECISION BIOSCIENCES INC | Kelly John Alexander | Officer - Chief Financial Officer | Biological Products, (No Diagnostic Substances) | OPT+S | $4.03 | 15,213 | -$61,308 | 106,448 | 0.0% |
| 2026-01-23 02:48 | 2026-01-21 | DTIL | PRECISION BIOSCIENCES INC | SMITH J. JEFFERSON | Officer - Chief Research Officer | Biological Products, (No Diagnostic Substances) | OPT+S | $4.03 | 10,200 | -$41,106 | 110,184 | 0.0% |
| 2026-01-23 00:30 | 2026-01-20 | AERG | Applied Energetics Inc. | MCCAHON STEPHEN WILLIAM | Officer - Chief Science Officer | Search, Detection, Navigation, Guidance, Aeronautical Sys | SELL | $1.80 | 10,000 | -$18,000 | 12,772,861 | -0.1% |
| 2026-01-23 00:57 | 2026-01-20 | AIRG | Airgain Inc. | SUEN JACOB | Director, Officer - President and CEO | Radio & Tv Broadcasting & Communications Equipment | SELL | $4.00 | 15,993 | -$63,908 | 293,635 | -5.2% |
| 2026-01-23 00:56 | 2026-01-20 | AIRG | Airgain Inc. | Sadri Ali | Officer - Chief Technology Officer | Radio & Tv Broadcasting & Communications Equipment | SELL | $4.00 | 4,733 | -$18,914 | 127,030 | -3.6% |
| 2026-01-23 00:53 | 2026-01-20 | AIRG | Airgain Inc. | Elbaz Michael | Officer - Chief Financial Officer | Radio & Tv Broadcasting & Communications Equipment | SELL | $4.00 | 4,587 | -$18,330 | 133,106 | -3.3% |
| 2026-01-22 20:36 | 2026-01-21 | RCG | RENN Fund, Inc. | STAHL MURRAY | Officer, 10% owner - President/Co-Portfolio Manager | Other | BUY | $2.70 | 1,134 | $3,062 | 64,334 | +1.8% |
| 2026-01-22 21:04 | 2025-12-12 | OGEN | ORAGENICS INC | Telling Fred | Director | Pharmaceutical Preparations | SELL | $0.94 | 210 | -$198 | 948 | -18.1% |
| 2026-01-23 01:31 | 2026-01-20 | USIO | Usio, Inc. | National Services, Inc | 10% owner | Functions Related To Depository Banking, NEC | SELL | $1.36 | 17,512 | -$23,818 | 2,776,485 | -0.6% |
| 2026-01-23 01:07 | 2026-01-20 | CMU | MFS HIGH YIELD MUNICIPAL TRUST | Bulldog Investors, LLP | 10% owner | Other | BUY | $3.50 | 678 | $2,373 | 24,878 | +2.8% |
| 2026-01-22 00:05 | 2026-01-16 | OTH | OFF THE HOOK YS INC. | Gonnelli Robert Rosario | Director | Ship & Boat Building & Repairing | BUY | $2.60 | 5,000 | $13,000 | 162,000 | +3.2% |
| 2026-01-22 00:01 | 2026-01-21 | DTI | Drilling Tools International Corp | Domino Michael Wayne Jr. | Officer - President, DTR Division | Oil & Gas Field Machinery & Equipment | SELL | $4.00 | 24,996 | -$99,984 | 1,433,054 | -1.7% |
| 2026-01-22 02:13 | 2026-01-16 | CLNN | Clene Inc. | Ugwumba Chidozie | 10% owner | Pharmaceutical Preparations | SELL | $4.97 | 32,474 | -$161,519 | 617,824 | -5.0% |
| 2026-01-21 17:09 | 2026-01-16 | IMRX | Immuneering Corp | Brakewood Harold Eugene | Officer - Chief Business Officer | Pharmaceutical Preparations | BUY | $4.76 | 5,250 | $24,990 | 11,050 | +90.5% |
| 2026-01-22 02:56 | 2026-01-21 | CABA | Cabaletta Bio, Inc. | Chang David J. | Officer - Chief Medical Officer | Biological Products, (No Diagnostic Substances) | BUY | $2.26 | 8,800 | $19,888 | 8,800 | +100.0% |
| 2026-01-22 02:56 | 2026-01-21 | CABA | Cabaletta Bio, Inc. | Binder Gwendolyn | Officer - President, Science & Tech. | Biological Products, (No Diagnostic Substances) | BUY | $2.19 | 11,312 | $24,763 | 31,312 | +56.6% |
| 2026-01-22 02:55 | 2026-01-21 | CABA | Cabaletta Bio, Inc. | Gavel Steve | Officer - Chief Commercial Officer | Biological Products, (No Diagnostic Substances) | BUY | $2.27 | 22,170 | $50,215 | 22,170 | +100.0% |
| 2026-01-22 02:54 | 2026-01-21 | CABA | Cabaletta Bio, Inc. | Bollard Catherine | Director | Biological Products, (No Diagnostic Substances) | BUY | $2.27 | 4,405 | $9,982 | 5,405 | +440.5% |
| 2026-01-22 02:53 | 2026-01-21 | CABA | Cabaletta Bio, Inc. | Gerard Michael | Officer - General Counsel | Biological Products, (No Diagnostic Substances) | BUY | $2.27 | 6,600 | $14,979 | 6,600 | +100.0% |
| 2026-01-21 20:46 | 2026-01-21 | XCUR | EXICURE, INC. | Exicure HiTron Inc. | 10% owner | Pharmaceutical Preparations | SELL | $4.50 | 258,367 | -$1,162,652 | 1,598,947 | -13.9% |
| 2026-01-22 01:03 | 2026-01-20 | BCDA | BioCardia, Inc. | Altman Peter | Director, Officer - President and CEO | Biological Products, (No Diagnostic Substances) | BUY | $1.33 | 900 | $1,194 | 268,866 | +0.3% |
| 2026-01-22 02:30 | 2026-01-20 | ZIP | ZIPRECRUITER, INC. | Garefis Amy | Officer - EVP, Chief People Officer | Services-Computer Programming, Data Processing, Etc. | SELL | $2.64 | 2,847 | -$7,521 | 211,578 | -1.3% |
| 2026-01-22 02:28 | 2026-01-20 | ZIP | ZIPRECRUITER, INC. | SHIMANOVSKY BORIS F. | Officer - EVP, Chief Technology Officer | Services-Computer Programming, Data Processing, Etc. | SELL | $2.61 | 5,650 | -$14,739 | 336,287 | -1.7% |
| 2026-01-22 02:34 | 2026-01-20 | ZIP | ZIPRECRUITER, INC. | SAKAMOTO RYAN T. | Officer - EVP, Chief Legal Officer | Services-Computer Programming, Data Processing, Etc. | SELL | $2.62 | 2,169 | -$5,673 | 118,598 | -1.8% |
| 2026-01-22 02:55 | 2026-01-21 | CABA | Cabaletta Bio, Inc. | Tomasello Shawn | Director | Biological Products, (No Diagnostic Substances) | BUY | $2.21 | 22,725 | $50,322 | 22,725 | +100.0% |
| 2026-01-22 02:54 | 2026-01-21 | CABA | Cabaletta Bio, Inc. | Nichtberger Steven | Director, Officer - President & CEO | Biological Products, (No Diagnostic Substances) | BUY | $2.24 | 45,000 | $100,778 | 1,031,483 | +4.6% |
| 2026-01-21 18:11 | - | COSM | Cosmos Health Inc. | Siokas Grigorios | Director, Officer, 10% owner - Chief Executive Officer | Wholesale-Drugs, Proprietaries & Druggists' Sundries | BUY | $0.50 | 353,321 | $175,000 | 8,091,795 | +4.6% |
| 2026-01-22 01:17 | 2026-01-20 | ESPR | Esperion Therapeutics, Inc. | Looker Benjamin | Officer - General Counsel | Pharmaceutical Preparations | SELL | $2.88 | 1,689 | -$4,868 | 384,216 | -0.4% |
| 2026-01-22 02:53 | 2026-01-21 | CABA | Cabaletta Bio, Inc. | Simon Mark | Director | Biological Products, (No Diagnostic Substances) | BUY | $2.28 | 11,061 | $25,261 | 147,205 | +8.1% |
| 2026-01-22 01:35 | 2026-01-20 | GEVO | Gevo, Inc. | Shafer Andrew | Officer - Chief Cust Mkt & Brnd Officer | Industrial Organic Chemicals | SELL | $1.99 | 5,000 | -$9,940 | 270,823 | -1.8% |
| 2026-01-22 00:54 | 2026-01-16 | CBDS | Dogecoin Cash, Inc. | TOBIAS DAVID | Director, Officer, 10% owner - CEO | Services-Personal Services | SELL | $0.02 | 430,551 | -$8,353 | 25,828,000 | -1.6% |
| 2026-01-22 00:05 | 2026-01-16 | PALI | PALISADE BIO, INC. | Williams Donald Allen | Director | Biological Products, (No Diagnostic Substances) | BUY | $1.67 | 5,000 | $8,356 | 10,728 | +87.3% |
| 2026-01-22 03:17 | 2026-01-20 | SER | Serina Therapeutics, Inc. | Moreadith Randall | Officer - Chief Scientific Officer | Pharmaceutical Preparations | OPT+S | $3.04 | 4,000 | -$12,140 | 0 | 0.0% |
| 2026-01-22 05:35 | 2026-01-16 | MIGI | Mawson Infrastructure Group Inc. | Endeavor Blockchain, LLC | 10% owner | Finance Services | BUY | $4.68 | 140,000 | $655,200 | 1,400,000 | +11.1% |
| 2026-01-21 19:12 | 2026-01-20 | RCG | RENN Fund, Inc. | STAHL MURRAY | Officer, 10% owner - President/Co-Portfolio Manager | Other | BUY | $2.69 | 1,134 | $3,050 | 64,252 | +1.8% |
| 2026-01-21 22:10 | 2026-01-20 | IRIX | IRIDEX CORP | Dizon Romeo R | Officer - Chief Financial Officer | Electromedical & Electrotherapeutic Apparatus | BUY | $1.50 | 4,259 | $6,380 | 100,440 | +4.4% |
| 2026-01-20 18:29 | 2025-10-17 | MYNZ | MAINZ BIOMED N.V. | Donahue Kevin Michael | 10% owner | Pharmaceutical Preparations | BUY | $1.51 | 685,000 | $1,034,350 | 685,000 | +100.0% |
| 2026-01-21 00:10 | 2026-01-15 | BLND | Blend Labs, Inc. | Kneafsey Brian | Officer - Head of Revenue | Services-Computer Programming, Data Processing, Etc. | SELL | $3.06 | 25,000 | -$76,420 | 649,824 | -3.7% |
| 2026-01-21 00:41 | 2026-01-16 | NXDR | Nextdoor Holdings, Inc. | How Antoinette | Officer - Chief Accounting Officer | Services-Computer Programming, Data Processing, Etc. | OPT+S | $1.95 | 13,935 | -$27,124 | 18,270 | 0.0% |
| 2026-01-21 00:40 | 2026-01-16 | NXDR | Nextdoor Holdings, Inc. | Schwartz Sophia | Officer - General Counsel and Secretary | Services-Computer Programming, Data Processing, Etc. | OPT+S | $1.95 | 23,278 | -$45,299 | 286,587 | 0.0% |
| 2026-01-21 02:56 | 2026-01-16 | NRDY | Nerdy Inc. | Paszterko John Andrew | Officer - Chief Operating Officer | Services-Educational Services | SELL | $1.01 | 18,457 | -$18,642 | 581,543 | -3.1% |
| 2026-01-21 01:38 | 2026-01-20 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | Reynoso Jamie L. | Officer - CEO, Medicare Advantage | Hospital & Medical Service Plans | SELL | $2.58 | 4,597 | -$11,860 | 2,737,700 | -0.2% |
| 2026-01-21 01:38 | 2026-01-15 | NKTX | Nkarta, Inc. | Mahmood Nadir | Officer - President | Pharmaceutical Preparations | SELL | $2.07 | 5,649 | -$11,693 | 167,727 | -3.3% |
| 2026-01-20 22:09 | 2026-01-16 | XCUR | EXICURE, INC. | Exicure HiTron Inc. | 10% owner | Pharmaceutical Preparations | SELL | $4.50 | 734,747 | -$3,306,362 | 1,857,314 | -28.3% |
High Risk, High Reward Insider Trades
Penny stocks are notoriously volatile, but when insiders put their own money into stocks priced under $5, it provides a unique layer of validation. Unlike large-cap stocks where buys might be routine, a million-share purchase at $0.50 can indicate that management sees a path to recovery or exponential growth. Our tracking allows you to identify ini speculative signals in real-time, focusing on the capital flow of those with intimate industry knowledge. Following these low-cap moves helps bridge the information gap in the most volatile market segments.
Identifying Legitimate Micro-Cap Conviction
Our Penny Stock Filter isolates the most speculative yet promising filings from the SEC Form 4 feed. By focusing on low-priced equities, we highlight where CEOs and Directors are taking meaningful positions. This list is essential for small-cap investors looking to follow the capital of those with intimate knowledge of a company's research, patents, or upcoming regulatory approvals. Eliminate the noise and focus strictly on high-impact accumulation from leadership betting big on their company’s future value in the micro-cap space.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.